You are visiting us from Virginia. You are located in HHS Region 3. Your Center is Central East ATTC.

Products and Resources Catalog

Product Type
Target Audience
Date Range
The New England ATTC in partnership with RICARES provided a basic/universal TA session titled “State-level homelessness and drug overdose mortality: Evidence from US panel data” on 3/21/24 from 12:30 PM to 1:30 PM. Although we in recovery science understand well that not having access to steady, safe, and secure housing is a risk factor for drug overdose for a given individual, less is known about the relationship between homelessness and overdose mortality (the rate of death resulting from drug overdose) at the state level. In this study, researchers looked at data on housing, population, substance use, overdose, unemployment, and other variables from 2007–2020 for all US states and Washington DC. The result was that overdose mortality was found to be positively associated with homelessness at the state level in other words, the more homelessness there is in a state, the higher the state’s overdose mortality rate is likely to be. However, they found that this association becomes weaker when fentanyl is widely available in a given state. Researchers concluded that, given this association, policies, and programs to prevent and reduce homelessness should be considered critical elements of overdose prevention efforts. Article link: Please find the meeting summary here: ATTC ReadingGroup 03212024 Summary
Published: March 22, 2024
The risk of fatal overdose has changed significantly in recent years, most notably with the emergence of the illicit opioid fentanyl and the increasing prevalence of polypharmacy. In this webinar, presenters Michael Hite, MBA and Desislav Hite, MD discussed trends and patterns in overdose cases over the last 5 years, factors that can increase overdose risk including identifiable life events and mental health co-occurring conditions, and how different populations are affected across Region 10. They also discussed actionable interventions to enhance overdose safety including new medical devices and digital resources, harm reduction strategies, and collaboration with local community organizations. Download slides | View recording
Published: August 24, 2023
eNewsletter or Blog
  The Great Lakes Current is the e-newsletter of the Great Lakes ATTC, MHTTC, and PTTC.   The August 2023 issue honors International Overdose Awareness Day (August 31), opioid overdose prevention training on HealtheKnowledge, and the newest NIATx in New Places series blog post written by Lynn Madden, PhD, MPA.  And as always, you will find links to all upcoming events and trainings hosted by the Great Lakes ATTC, MHTTC, and PTTC!  
Published: August 3, 2023
Question and Answer Webinar titled: Unmasking the Crisis: Exploring Intentional Substance Use Disorder Overdoses Among the Hispanic/Latino Population Understanding the Factors, Addressing the Crisis, and Promoting Resilience   About the Panelists DR. CRISTINA RABADAN-DIEHL, PHARMD, PHD, MPH After 25 years at the National Institutes of Health and the Department of Health and Human Services, Dr. Rabadán-Diehl joined Westat in 2018. A multidisciplinary scientist with extensive experience in chronic non-communicable diseases and global health, Dr. Rabadán-Diehl serves as a scientific lead in several projects in addition to developing partnerships with domestic and international government and nongovernment stakeholders.   DR. FERNANDO J. GONZALEZ Dr. Fernando J. Gonzalez has more than 37 years of experience managing public health programs and projects in the United States, México, U.S.-México Border, and Global South Countries. He currently serves as Manager for the EMS Opioid Rapid Response and Prevention Program, UTHealth Science Center San Antonio/Project Vida, El Paso, TX.   DR. J ROCKY ROMERO, PHD, LMSW As the Owner and CEO of JR Romero & Associates, Dr. J. Rocky Romero has been a pioneer in the development, evaluation, and consultation of behavioral health programs for 22 years. A former Assistant Professor at the New Mexico Highlands University School of Social Work in Albuquerque, NM, Dr. Romero has an extensive academic background in social work. In addition, he was a member of Governor Richardson's Higher Education Cultural Competency Taskforce. Resources Presentation Handouts: (Dr Gonzalez) and (Dr Rabadán Diehl) Hispanic health in the USA: a scoping review of the literature | Public Health Reviews | Full Text ( Putting Equitable Implementation Science Into Research and Practice ( Evidence-Based Practices Registry ( Home | Suicide;StopIt NM ( Bienvenido Program Engages Latinx Communities to Implement Better Mental Health Interventions ( Familia Adelante: A Substance Use Prevention and Stress Reduction Program for Latino Adolescents – NNEDShare
Published: July 13, 2023
Presenters: Maya Magarati, PhD, and Angela Gaffney, MPA (Seven Directions) Seven Directions (UW Department of Psychiatry & Behavioral Sciences) is hosting the 2023 Our Nations, Our Journeys (ONOJ) conference June 27-29 in Minnesota, a biannual, in-person gathering of 300 tribal and urban Indian public and behavioral health practitioners, leaders, researchers, and Indigenous students focusing on healing from the opioid epidemic. This webinar, presented by Maya Magarati, PhD, and Angela Gaffney, MPA, will outline Seven Directions’ core visions and framework against a backdrop of ONOJ, discuss ways to appropriately engage with Indigenous communities, and spotlight (1) the development and implementation of an Indigenous Evaluation Toolkit for tribal public health programs, and (2) other opioid overdose prevention resources and communities of practice for tribal public health practitioners as facilitated by Seven Directions. Download slides | Watch recording    Webinar keyword: Specific populations
Published: June 8, 2023
    DESCRIPTION: As the illicit opioid supply includes more and more fentanyl, there have been increasing concerns about increasing rates of buprenorphine initiation precipitating opioid withdrawal. This session will describe why we believe this is happening, how common it is, and buprenorphine initiation strategies to support patients in avoiding precipitated withdrawal.     LEARNING OBJECTIVES: Describe the challenges of buprenorphine initiation in the fentanyl era. Name three potential approaches to buprenorphine initiation. Counsel on reducing fentanyl-related harms.     TRAINER: Elizabeth Salisbury-Afshar, MD, MPH is an Associate Professor in the Departments of Family Medicine and Community Health and Population Health Sciences at the University of Wisconsin School of Medicine and Public Health in Madison, Wisconsin. She is the Program Director of the Preventive Medicine Residency and core Faculty for the Addiction Medicine Fellowship. Dr. Salisbury-Afshar is board certified in family medicine, preventive medicine/public health and addiction medicine and her expertise lies at the intersection of these fields. Her work has focused on expanding access to evidence-based substance use disorder treatment and harm reduction services. Past public health roles include serving as Medical Director of Behavioral Health Systems Baltimore, Medical Director at Heartland Alliance Health (a healthcare for the homeless provider in Chicago), and Medical Director of Behavioral Health at the Chicago Department of Public Health. Dr. Salisbury-Afshar received her Medical Degree from Rush University Medical College and her Master’s in Public Health from John Hopkins Bloomberg School of Public Health.     The Great Lakes A/MH/PTTC is offering this training for individuals working in HHS Region 5: IL, IN, MI, MN, OH, WI. This training is being provided in response to a need identified by Region 5 stakeholders.
Published: April 20, 2023
Print Media
This snapshot of information is intended to provide resources to individuals, parents, professionals, and providers on xylazine use and its impact on communities across the United States. Español Xilazina 101: El uso de la Xilazina y Su Impacto en las comunidades de los Estados Unidos Esta reseña de información tiene por objeto proporcionar recursos a las personas, padres, profesionales y proveedores sobre el uso de la xilazina y su impacto en las comunidades de Estados Unidos
Published: April 7, 2023
Print Media
This snapshot of information is intended to provide resources to individuals, parents, professionals, and providers on fentanyl use among Latinos in the United States. HOJA INFORMATIVA SOBRE EL FENTANILO PARA LOS PROVEEDORES Esta síntesis de información tiene por objeto proporcionar recursos a las personas, los padres, los profesionales y los proveedores sobre el consumo de fentanilo entre los Latinos en los Estados Unidos.
Published: March 30, 2023
This FREE 2-part virtual learning series was designed to enhance education and training related to the pre and post migration risk factors that contribute to substance use disorders (SUD) among Hispanic/Latino immigrant youth and provides screening, intervention, and referral to treatment tools to non-clinical professionals working with this population. The series addresses research data related to SUD in Hispanic/Latino immigrant youth, introduces basic alcohol, tobacco, and other drug abuse (ATODA) training, focuses on the early identification and prevention of behavioral, and emotional problems, as well as identifying signs and symptoms of co-occurring mental health issues. The series also provides information on assessing early signs and symptoms of SUD and highlights the importance of basic parenting/caregiver supervision and monitoring for those caring for unaccompanied immigrant youth. Lastly, the presenters will discuss developmental and SUD related issues, and introduces a culturally adapted approach to delivering Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Hispanic/Latino immigrant youth. At the end of the 2-part virtual learning series, non-clinical professionals will have reviewed the dynamics of facilitating a culturally responsive SBIRT intervention in preventing, eliminating substance use, and supporting healthy adjustment and wellbeing in Hispanic/Latino immigrant youth. Session 1: Early Identification of Pre and Post Migration Risk Factors of Substance Use Disorders in Hispanic/Latino Youth Date: December 1st, 2022 Time: 12:00pm-1:30pm MST/ 2:00pm-3:30pm ET   View Presentation Download Presentation Handouts Learning Objectives: Participants will be able to: Understand basic ATODA use and abuse data as it relates to the general population compared to Hispanic/Latino immigrant youth Assess and identify pre and post migration trauma in early identification and co-occurring issues in relation to substance use in the Hispanic/Latino immigrant youth Assess behavioral and emotional problems in early identification and prevention of substance use in Hispanic/Latino immigrant youth Identify parenting related issues to promote positive parenting skills in the prevention of substance use in the Hispanic/Latino youth population   Session 2: A Migration Informed Context for Delivering Screening, Brief Intervention, and Referral to Treatment (SBIRT) with Hispanic/Latino Immigrant Youth Date: January 12th, 2023 Time: 12:00pm-1:30pm MST/ 2:00pm-3:30pm ET   View Presentation Download Presentation Handouts Learning Objectives: Participants will be able to: List migration related experiences that impact development and coping with immigrant youth Define cultural bereavement and its correlation with substance use Describe components of, Screening, Brief Intervention, and Referral to Treatment, (SBIRT) Identify opportunities for cultural adaptations with SBIRT with immigrant youth Identify factors of a culturally responsive rapport and engagement for screening List benefits of the person-centered approach using core skills of motivational interviewing in a brief intervention interaction List cultural considerations for a referral to treatment and language conducive terminology   About the Presenters Richard Cervantes, Ph.D. Dr. Cervantes is Research Director of Behavioral Assessment, Inc. Dr. Cervantes was a Research Psychologist at the UCLA Spanish Speaking Mental Health Research Center and held a full-time faculty appointment in the USC School of Medicine, Department of Psychiatry, and the Behavioral Sciences. Dr. Cervantes is Co-Investigator on the Duke University, NIH Supported “Ser Hispano” study on acculturation stress and biomarkers. He was also the Principal Investigator for the NIH funded study, “Development of the Hispanic Stress Inventory-2” and PI on the recently completed the NIH drug prevention study “Familia Adelante: A multi risk Prevention Program for Hispanic Youth”. Dr. Cervantes is also a leader in evaluation science with special expertise in cultural competency and cross-cultural instrument development. He is the lead evaluator for the SAMHSA Hispanic and Latino Addiction and Prevention Technology Transfer Centers (TTCs). He has published extensively in peer review journals, books, and special reports. He is on the editorial board for the Hispanic Journal of Behavioral Sciences and sits on a number of national, local and university based advisory boards. Dr. Cervantes received his Ph.D. in Clinical Psychology from Oklahoma State University.   Diana Padilla, CLC, CARC, CASAC-T Diana Padilla, RCR, CASAC-T, is Research Project Manager at the New York State Psychiatric Institute, Division of Substance Use Disorders, Columbia University Medical Center. Ms. Padilla provides intensive technical assistance in two organizational capacity-building initiatives; the implementation of SBIRT (Screening, Brief Intervention, and Referral to Treatment), and the integration of Equity and Inclusion strategies to improve service delivery and address behavioral health disparities for marginalized communities. Both projects are facilitated for the Northeast and Caribbean Technology Transfer Center (NeCATTC), HHS Region 2. Ms. Padilla also Chairs the National Committee on Behavioral Health Equity & Inclusion committee for the Addiction Technology Transfer Center. The working group focuses on disseminating the application of CLAS standards and other related topics and technical assistance initiatives to help organizations address disparities in behavioral health care. Ms. Padilla is also a Senior Trainer with more than 23 years of public health service, instructing behavioral health practitioners, prevention specialists and drug court professionals on addictions and recovery supporting best practices.
Published: December 7, 2022
Print Media
La falta de aceptación puede interferir con los atentos de ampliar el uso de tratamientos asistidos por medicamentos (TAM) para los trastornos por consumo de sustancias (TCS). Las Hojas Informativas de TAM ofrecen estrategias para generar apoyo para esta práctica basada en evidencia.  Hoja Informativa #1: Asegurando la Aceptación              Hoja Informativa #2: Reduciendo el Riesgo de Uso Indebido y la Desviación              Hoja Informativa #3: Abogando por las Medicamentos 
Published: September 14, 2022
Print Media
Lack of buy-in can interfere with attempts to expand use of medication-assisted treatment (MAT) for substance use disorders. These three fact sheets offer strategies to build support for this evidence-based practice.  MAT Fact Sheet #1: Securing Buy-in            MAT Fact Sheet #2: Reducing Risk of Misuse and Diversion          MAT Fact Sheet #3: Making the Case for Medication
Published: September 14, 2022
In partnership with Brown University SciToons and the Department of Emergency Medicine, the New England ATTC created the product "Opioid Overdose Rescue: 5 Ways to Save the Life." This educational video teaches the viewer how to recognize an overdose and how to effectively intervene. Watch the video to learn more. 
Published: September 1, 2022
Print Media
Harm reduction is any action that reduces risk and increases personal and public safety. Harm reduction approaches have proven to prevent death, injury, disease, overdose, prevent substance misuse or disorder and most of us practice harm reduction techniques daily. For example, when we wear a seatbelt or apply sunscreen we are using harm reduction strategies.  Fentanyl strips, naloxone, and needle exchange programs are also examples of harm reduction.  This poster identifies some of the most common harm reduction methods in an attempt to normalize the term "harm reduction" and broaden the definition.   The Spanish translations were prepared by consultants for the Mountain Plains ATTC. While reasonable efforts are made to provide accurate translations, acknowledging the diversity of Spanish and English Language, some words/phrases may differ.   The poster can be downloaded in multiple formats directly from the MPATTC website. This product was designed for display as an 11x17 sized poster in a location most visible and accessible to behavioral health providers, educators, and/or peer recovery specialists but is also available in an 8.5x11 format for in-house printing. In addition, hard copies may be requested from the MPATTC by emailing us at [email protected] (posters can be mailed within the continental United States). Please click on the link below for more information.   To request an 11x17 "What is Harm Reduction?" poster to be mailed directly to you, please click "REQUEST A HARD COPY".  
Published: June 17, 2022
Print Media
Fatal overdoses are skyrocketing, and rates of substance use remain high, demonstrating the need to expand substance use disorder (SUD) treatment. In 2020, fatal overdoses in the Central East increased 25% (from 9,909 to 12,377), with overdose rates above the national average in every state except Virginia. Rates of substance use and SUD are persistently elevated. Funding additional treatment services and expanding access to existing treatment can help address the problem. This factsheet provides statistics and justifications for increasing SUD treatment.
Published: May 28, 2022
Print Media
The New England ATTC co-hosted the Recovery Science and Harm Reduction (RSHR) Reading Group meeting on March 09, 2022 from 12:30 PM to 1:30 PM. This discussion reviewed the article, “Hoots and harm reduction: a qualitative study identifying gaps in overdose prevention among women who smoke drugs.”  View the March 2022 RSHR Reading group meeting summary that includes a brief article summary and key themes that arose in discussion with the participants.
Published: March 17, 2022
eNewsletter or Blog
The March 2022 Dialogue contains articles on: Addiction: Equity-Grounded Leadership | Mental Health: Decreasing the Risk of Suicide for Black Boys | Prevention: Prevention Gambling | ORN: Peer Based Training | Regional Spotlight: Lost Dreams Awakening. Additional sections include upcoming training and webinar events, behavioral health observances, new resources, and Region 3 news. The Dialogue is designed to inform behavioral and mental health professionals of news and upcoming events in the Central East states. This electronic newsletter is disseminated bi-monthly on the first Tuesday. You are encouraged to provide us with any feedback or submit articles and topics for discussion in future issues of the newsletter, [email protected]. Sign up to receive the Dialogue in your mailbox. Visit the Dialogue Archives.
Published: March 1, 2022
  View the recorded webinar here:    Presented By: Mark Sanders, LCSW, CADC February 3, 2022   DESCRIPTION Frederick Douglass escaped slavery to become a national leader in the abolitionist movement. Malcolm X overcame a troubled childhood and a prison sentence to gain prominence as one of leading civil rights activists in the U.S. Both Douglass and Malcolm X offer lessons and implications for counseling African Americans with substance use disorders today.   You can read more on this topic in the article, "Lessons from the Recovery Legacies of Frederick Douglass and Malcolm X" by Mark Sanders. 
Published: February 3, 2022
Sponsored by: California Department of Health Care Services (CA DHCS), Opioid and Stimulant Implementation Support-Training and Technical Assistance (OASIS-TTA)-MAT Expansion Project, UCLA Integrated Substance Abuse Programs (UCLA ISAP), Pacific Southwest Addiction Technology Transfer Center (PSATTC), HHS Region 9, & Opioid Response Network STR-TA   Course Description This session will address “The Fourth Wave” of the opioid epidemic, including recent data on rising mortality due to fentanyl alone and in combination with methamphetamine. The rise of polysubstance use, including the use of the so called “goofball,” has implications for morbidity and mortality and raises the complexity of treatment. Treatment options, including use of medications, will be discussed. The session will also cover harm reduction strategies including naloxone, drug surveillance, and drug checking. This session will also include training on how to use fentanyl test strips, as part of a comprehensive public health and harm reduction strategy. Fentanyl test strips are a practical and effective tool for people who use drugs as means to encourage overdose risk education and reduce risk of death. Training will include discussion on distribution, limitations, sourcing, messaging amongst other considerations in the application and administration of use. Launch Date: November 12, 2021   At the conclusion of the training, participants will be able to: 1. Recall the history, epidemiology and use patterns of two (2) drug classes, including synthetic opioids and stimulants. 2. Explain two (2) poly-drug use patterns involving synthetic opioids and methamphetamines and develop treatment strategies. 3. Propose three (3) harm reduction measures to prevent overdose deaths due to synthetic opioids. 4. Identify two (2) steps required when testing drug supply using Fentanyl Test Strips. CME Statements: The training course meets the qualifications for the provision of two (2.0) continuing medical education credits/contact hours (CMEs/CEHs). Continuing Education: The training course meets the qualifications for the provision of two (2.0) continuing education credits/contact hours (CEs/CEHs). Estimated time to complete the course: This course should take approximately 2 hours to complete. Cost: Free Disclosure statements: Dan Ciccarone, MD, MPH – University of California, San Francisco DISCLOSURES: Dr. Ciccarone is on the Scientific Advisory Board of Celero Systems and an expert witness in federal opioid litigation for Motley Rice LLC. All of the relevant financial relationships listed have been mitigated. Amanda Cowan, MS – CLARE|MATRIX DISCLOSURES: Reported no relevant financial relationships with commercial entities. Trainers: Dan Ciccarone, MD, MPH – University of California, San Francisco Amanda Cowan, MS – CLARE|MATRIX
Published: December 10, 2021
This month our National Hispanic and Latino ATTC and PTTC would like to support August’s Overdose Awareness Month and International Overdose Awareness Day, which takes place annually on August 31st.   Resources: #NLBHA #NHLATTC #NHLPTTC Español  Nuestros Centros Nacionales Hispano y Latino ATTC y PTTC desean apoyar el Mes de Concientización de Sobredosis de el mes de agosto y el Día Internacional de Concientización de Sobredosis, que tiene lugar anualmente el 31 de agosto.   Recursos: #NLBHA #NHLATTC #NHLPTTC Português Neste mês, nós gostaríamos de apoiar o Mês de Conscientização sobre a Overdose e o Dia Internacional de Conscientização sobre a Overdose, que ocorre anualmente em 31 de agosto.   Recursos: #NLBHA #NHLATTC #NHLPTTC
Published: August 10, 2021
Presenter: Jenna van Draanen, PhD, MPH, University of Washington July 2021 This one-hour webinar discussed the role of harm reduction in addiction treatment and how it fits with other systems of care. In addition to covering recent service use patterns in the Northwest, Dr. van Draanen shared evidence and lessons learned from her work with overdose prevention sites (a model of peer-run safe consumption sites) in Vancouver, Canada. The session covered changes in overdose prevention site utilization during COVID-19, the importance of peer involvement in service delivery, and outcomes associated with overdose prevention site utilization. Download slides
Published: July 29, 2021
This training focuses on reducing personal, public, and institutionalized biases around people with substance use disorder. We will learn details of drug use, overdose, and navigating the care continuum by someone with lived experience who is now a Peer Recovery Support Specialist in Kansas City, MO. We will look at this story and the role bias played in delaying and distressing the recovery process. Participants learn about types of stigma, addiction on the brain, and evidence-based practices in overdose response. There will be multiple opportunities to observe how bias affects their own experiences and to discuss ways to shift attitudes and improve actions which lead to better outcomes and more people in recovery. Click here to watch the presentation!
Published: June 9, 2021
Print Media
This document is designed to reduce this information gap and help individuals and organizations better understand how the legal landscape in their state may impact access to harm reduction services and supplies, including overdose Good Samaritan laws, which provide limited protection from criminal sanctions to encourage people to call for help in an overdose emergency.
Published: February 24, 2021
eNewsletter or Blog
The January 2021 Dialogue contains articles on: Addiction: New Year. New Hope. Black History Month | Mental Health: Addressing Mental Health in the Black Community | Prevention: Substance Use Prevention and Mentoring | ORN: Mentoring | Region 3 Spotlight: Danya's new ORN hire. Additional sections include upcoming training and webinar events, behavioral health observances, new resources, and Region 3 news. The Dialogue is designed to inform behavioral and mental health professionals of news and upcoming events in the Central East states. This electronic newsletter is disseminated bi-monthly on the first Tuesday. You are encouraged to provide us with any feedback or submit articles and topics for discussion in future issues of the newsletter, [email protected]. Sign up to receive the Dialogue in your mailbox.    
Published: February 9, 2021
Presentation Slides
JMU Substance Use Disorder Education Virtual Conference An inter-professional training in SUDE/SBIRT for faculty and community partners. Holly Ireland, LCSW-C, Co-Director of the Central East ATTC presented the presentation at the conference: Implementing SBIRT: Substance Use Disorders Education. This was a closed event.
Published: October 16, 2020
1 2

The ATTC Network understands that words have power. A few ATTC products developed prior to 2017 may contain language that does not reflect the ATTCs’ current commitment to using affirming, person-first language. We appreciate your patience as we work to gradually update older materials. For more information about the importance of non-stigmatizing language, see “Destroying Addiction Stigma Once and For All: It’s Time” from the ATTC Network and “Changing Language to Change Care: Stigma and Substance Use Disorders” from the Providers Clinical Support System (PCSS).